Form 8-K - Current report:
SEC Accession No. 0001213900-25-059263
Filing Date
2025-06-30
Accepted
2025-06-30 08:30:46
Documents
13
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247399-8k_synergy.htm   iXBRL 8-K 38872
2 PRESS RELEASE DATED JUNE 30, 2025 ea024739901ex99-1_synergy.htm EX-99.1 15614
  Complete submission text file 0001213900-25-059263.txt   222284

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE snyr-20250630.xsd EX-101.SCH 3020
4 XBRL LABEL FILE snyr-20250630_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE snyr-20250630_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0247399-8k_synergy_htm.xml XML 3558
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 251088842
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)